Navigation Links
Major New Resource for Bone and Mineral Disorders Released
Date:12/9/2008

Medical Reference and Online Edition Gives Coverage of Bone and Mineral Diseases and Disorders with New International Drug Formulary

WASHINGTON, Dec. 9 /PRNewswire/ -- The American Society for Bone and Mineral Research (ASBMR), the leading scientific organization for the study of bone diseases, announces the publication of the new seventh edition of the Primer on the Metabolic Bone Diseases and Disorders of Bone and Mineral Metabolism. The new edition reflects the rapid and exciting advances in research and the clinical practice management of diseases such as osteoporosis, metastatic bone diseases and inherited bone diseases. Earlier editions of this widely used text have proven to be an indispensable and trusted resource for medical students, residents, physicians and scientists involved in bone and mineral diseases and disorders.

The Primer presents the most current findings on diagnosis, laboratory evaluation, treatment, clinical presentations, risk factors and bone density characteristics of osteoporosis, primary hyperparathyroidism, Paget's disease of bone, childhood rickets, renal osteodystrophy and metastatic bone disease. The increased use of reference images in this edition provides material on the differential diagnosis of rare diseases or bone cancers that may present with common symptoms.

"Our goal with the Seventh Edition of the Primer was to create a worldwide perspective on the diseases and disorders of bone," said Primer Editor-in-Chief, Clifford Rosen, M.D., Director of Clinical and Translational Research at Maine Medical Center. "This book is a 'must have' resource for all clinicians involved with the diagnosis and treatment of patients with bone diseases, especially osteoporosis, other metabolic bone diseases and bone cancer."

Bone disease reaches across many specialties and disciplines, and this new edition is an excellent overview to metabolic bone disease in a concise, current and usable format. Physicians and scientists in internal medicine, pediatrics, orthopedics, primary care, geriatrics, obstetrics and gynecology, endocrinology, rheumatology, oncology and nephrology will benefit from the information provided here.

New material added to this edition includes:

  • Abnormalities in Bone and Calcium Metabolism Following Burns
  • Bone Cancer and Pain
  • Vascular Calcification
  • Bisphosphonate-Associated Osteonecrosis of the Jaw
  • New International Drug Formulary covering the most widely used drugs in major regions of the world

The highly regarded Primer was first published in 1990, with subsequent editions released every three years to reflect progress and new research in the bone field.

Of the sixth edition, customers have commented:

"I highly recommend this book ... to any physician caring for patients with bone diseases ... "

The ASBMR is the premier professional, scientific and medical society for the promotion of bone and mineral research and the translation of that research into clinical practice. To learn more, visit the ASBMR website at www.asbmr.org.

Copies of the print edition are available at medical bookstores, Amazon.com, or direct from ASBMR. To order, send email to primer@jbmr.org or download an order form at www.asbmrprimer.org. Site licenses for the Online Edition will also be available for institutional users.


'/>"/>
SOURCE American Society for Bone and Mineral Research
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Jane L. Delgado Appointed By Senate Majority Leader to Board of National Urban Air Toxics Research Center
2. Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks
3. NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder
4. Mini heart attacks lessen damage from major ones
5. Major North American breakthrough for dialysis patients
6. Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder
7. New Survey Shows Majority of Americans Need to Take Proper Steps to Manage Diabetes Risk
8. Hospital of the Future Report Urges Major Changes
9. America Reaches Major Anti-Smoking Milestone
10. Insure.com Examines Major Medical Mistakes Called Never Events
11. Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... PA (PRWEB) , ... September 22, 2017 , ... ... soon as possible, and they often saves lives. However, if one isn’t accessible ... to widen the availability of defibrillation, I came up with this idea," said ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... House buildings, and Richard Pedranti Architect (RPA), a full-service architecture firm ... strategic partner’s Solsken Line of Model Homes . Independently, Ecocor and RPA ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... Pennsylvania, is pleased to offer in-home and online newborn sleep consultations . ... has on the body,” says company owner Courtney Zentz, a pediatric sleep professional, ...
(Date:9/22/2017)... California (PRWEB) , ... September 22, 2017 , ... Happy ... at a time - carries it into the entertaining and delicious worlds of ... Matt Gersper (founder of Happy Living) convinced him to turn his play into a ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed with a Curse: ... tithe, and the freedom experienced when breaking free from this misconception. “Cursed with ... M. Harrison. , Published by Christian Faith Publishing, Lysa M. Harrison’s new book ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... , Sept. 7, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Healthcare Conference at the Grand Hyatt hotel in New ... 2017 at 11:40 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Medicine Technology: